Results 81 to 90 of about 13,380,482 (128)
The role of the Nocebo effect in the use of biosimilars in routine rheumatology clinical practice. [PDF]
Mediterr J Rheumatol, 2019 Kravvariti E, Kitas GD, Sfikakis PP.
europepmc +1 more source
The nocebo effect as a source of bias in the assessment of treatment effects. [PDF]
F1000Res, 2019 Wartolowska K.
europepmc +1 more source
Treatment Outcomes with Biosimilars: Be Aware of the Nocebo Effect. [PDF]
Rheumatol Ther, 2017 Rezk MF, Pieper B.
europepmc +1 more source
To See or NOsee: The Debate on the Nocebo Effect and Optimizing the Use of Biosimilars. [PDF]
Adv Ther, 2018 Rezk MF, Pieper B.
europepmc +1 more source
Correction to: To See or NOsee: The Debate on the Nocebo Effect and Optimizing the Use of Biosimilars. [PDF]
Adv Ther, 2018 Rezk MF, Pieper B.
europepmc +1 more source
The nocebo effect of drugs. [PDF]
Pharmacol Res Perspect, 2016 Planès S, Villier C, Mallaret M.
europepmc +1 more source
The nocebo effect challenges the non-medical infliximab switch in practice. [PDF]
Eur J Clin Pharmacol, 2018 Boone NW +10 more
europepmc +1 more source
A systematic review of sex differences in the placebo and the nocebo effect. [PDF]
J Pain Res, 2017 Vambheim SM, Flaten MA.
europepmc +1 more source